EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nano-Based Technology in Glioblastoma

Dorota Bartusik-Aebisher iD, Izabela Rudy, Karolina Pięta, David Aebisher iD

Molecules · 2025

DOI: 10.3390/molecules30173485 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Dorota Bartusik-Aebisher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and General Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-959 Rzeszów, Poland. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Nanotechnology. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 302 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neoplasms of the central nervous system (CNS) constitute a minor fraction of all malignant tumors. CNS accounts for approximately 4% of newly diagnosed oncological cases. Among primary CNS neoplasms, gliomas predominate, comprising nearly 90% of all malignant brain tumors, with Glioblastoma (GBM) representing the most prevalent and aggressive histological subtype. The earliest documented occurrences of GBM date back to the 19th century. Contemporary therapeutic modalities for GBM primarily involve maximal surgical resection, adjuvant radiotherapy, and systemic chemotherapy. However, the intrinsic heterogeneity of GBM poses a formidable obstacle to treatment efficacy. The immunosuppressive tumor microenvironment, coupled with the restrictive nature of the blood–brain barrier (BBB), significantly limits the intratumorally delivery of chemotherapeutic agents. The emergence of nanotechnology in the biomedical domain has been driven by the urgent need to develop more effective and targeted anticancer interventions. Optimizing therapeutic outcomes necessitates the concurrent application of multimodal strategies. This review emphasizes the Nano-Based Technology in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsNanotechnologyHumansBlood-Brain BarrierTumor MicroenvironmentAnimalsDrug Delivery SystemsAntineoplastic Agents

Stichwörter der Autor:innen

central nervous systemglioblastomananotechnology

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Biochemistry and General Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-959 Rzeszów, Poland.
  • Student Scientific Club of Biochemists URCell, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-959 Rzeszów, Poland.
  • Department of Photomedicine and Physical Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-959 Rzeszów, Poland.

ORCID-Profile: Dorota Bartusik-Aebisher, David Aebisher

Zitieren

APA

Bartusik-Aebisher, D., Rudy, I., Pięta, K., & Aebisher, D. (2025). Nano-Based Technology in Glioblastoma. Molecules. https://doi.org/10.3390/molecules30173485

Vancouver

Bartusik-Aebisher D, Rudy I, Pięta K, Aebisher D. Nano-Based Technology in Glioblastoma. Molecules. 2025. doi:10.3390/molecules30173485

BibTeX
@article{BartusikAebisher2025,
  author = {Bartusik-Aebisher, Dorota and Rudy, Izabela and Pięta, Karolina and Aebisher, David},
  title = {Nano-Based Technology in Glioblastoma},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30173485}
}
Kostenlos starten →